Assessment of the Potential Adverse Events Related to Ribavirin-Interferon Combination for Novel Coronavirus Therapy

PURPOSE: We aimed to analyze and evaluate the safety signals of ribavirin-interferon combination through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS), so as to provide reference for the rationale use of these agents in the management of relevant toxicitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Wenya, Hong, Dongsheng, Zhu, Jieqiang, Zhao, Qingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532425/
https://www.ncbi.nlm.nih.gov/pubmed/33029193
http://dx.doi.org/10.1155/2020/1391583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532425/
https://www.ncbi.nlm.nih.gov/pubmed/33029193
http://dx.doi.org/10.1155/2020/1391583

Ejemplares similares